Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvage Therapy vs High-Dose Chemo with Stem Cell Support in Ovarian Cancer
NCT00002819Phase 3Terminated
- Sponsor
- GOG Foundation
- Start
- Nov 1996
- Primary completion
- Feb 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, mitoxantrone, cyclophosphamide in ovarian cancer, sponsored by GOG Foundation. Started Nov 1996; status: terminated.
02
Drugs
carboplatinmitoxantronecyclophosphamide
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00002819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002819.